George F Tidmarsh's Net Worth
$492 Million
Who is George F Tidmarsh?
George F Tidmarsh has an estimated net worth of $492 Million. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., REVELATION BIOSCIENCES, INC., ANAVEX LIFE SCIENCES CORP., SPECTRUM PHARMACEUTICALS INC, THRESHOLD PHARMACEUTICALS INC, and LA JOLLA PHARMACEUTICAL CO.
SEC CIK
George F Tidmarsh's CIK is 0001287235
Past Insider Trading and Trends
2019 was George F Tidmarsh's most active year for acquiring shares with 23 total transactions. George F Tidmarsh's most active month to acquire stocks was the month of February. 2023 was George F Tidmarsh's most active year for disposing of shares, totalling 7 transactions. George F Tidmarsh's most active month to dispose stocks was the month of August. 2014 saw George F Tidmarsh paying a total of $496,050.00 for 234,000 shares, this is the most they've acquired in one year. In 2023 George F Tidmarsh cashed out on 67,502 shares for a total of $42,761.16, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Odonate Therapeutics, Inc. (ODTC) Snapshot price: $3210
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 151.29K |
—
|
—
| 151.29K |
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REVELATION BIOSCIENCES, INC. (REVB) Snapshot price: $2.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -27.77K |
$0.52 | -$14,438.14 |
0
|
Dec 8
| |||
Form 4
| -6.23% | -1.84K |
$0.65 | -$1,199.43 | 27.77K |
Oct 16
| |||
Form 4
| -20.65% | -10.96K |
$0.66 | -$7,242.58 | 42.1K |
Oct 16
| |||
Form 4
| -3.28% | -1.43K |
$0.69 | -$986.01 | 42.1K |
Sep 28
| |||
Form 4
| -39.32% | -25.50K |
$0.74 | -$18,895.00 | 39.35K |
Sep 14 - Sep 18
| |||
Form 4
| +385.83% | 51.5K |
$1.16 | $59,740.00 | 64.85K |
Apr 17 - Apr 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 4
| +4.47% | 20K |
$1.60 | $32,000.00 | 467.16K |
Feb 25
| |||
Form 4
| +7.45% | 31K |
$2.55 | $79,139.00 | 447.16K |
Feb 8 - Feb 9
| |||
Form 4/A
| +2.75% | 52K |
$2.51 | $132,936.07 | 1.94M |
Feb 4 - Feb 7
| |||
Form 4
| +3.39% | 50K |
$2.56 | $128,036.07 | 1.52M |
Feb 4 - Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANAVEX LIFE SCIENCES CORP. (AVXL) Snapshot price: $5.635
Executive Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 8K |
$1.25 | $10,000.00 | 8K |
Feb 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SPECTRUM PHARMACEUTICALS INC No price found
CSO and Head R&D Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 20K |
—
|
—
| 40K |
Jan 3
| |||
Form 4
| +33.33% | 5K |
$4.03 | $20,150.00 | 20K |
Aug 13
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
THRESHOLD PHARMACEUTICALS INC (MTEM) Snapshot price: $3.7
Founder and President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.40% | 4K |
$5.95 | $23,787.05 | 992.22K |
Mar 10 - Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||